Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04529655 · ClinicalTrials.gov registry record
Digital Capillary Refill for Monitoring of Sepsis
A clinical trial of Sepsis, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT04529655: Completed study of Sepsis, sponsored by Oregon Health and Science University.
NCT04529655 is a study of Sepsis that has completed, run by Oregon Health and Science University. The registered enrollment target is 26 participants, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04529655, a study of Sepsis, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Observational study for monitoring of capillary refill time in sepsis
Primary Outcome
Correlation of Capillary refill to blood lactate
Conditions Studied
Interventions
- DEVICE Capillary Refill Assessment
Study Locations (1)
Oregon
- OHSU - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-08-12 |
| Est. Completion | 2023-11-01 |
What the finished NCT04529655 record still lists
NCT04529655 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Capillary Refill Assessment is the first listed.
NCT04529655 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04529655 about?
NCT04529655 is a clinical study titled "Digital Capillary Refill for Monitoring of Sepsis". Observational study for monitoring of capillary refill time in sepsis
What is the current status of trial NCT04529655?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2020-08-12. Estimated completion is 2023-11-01.
What conditions does trial NCT04529655 study?
This clinical trial studies the following conditions: Sepsis.
What interventions are being tested in trial NCT04529655?
The interventions under investigation include: Capillary Refill Assessment (DEVICE).
Who is sponsoring clinical trial NCT04529655?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04529655 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04529655's enrollment target sits among peer trials
26 81st of 90 higher than 10 of 90 other Sepsis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI